1 citations
,
September 2022 in “International Journal of Trichology” Tofacitinib can be effective in treating hair loss caused by alopecia areata.
March 2024 in “Jurnal Tata Rias” Ginger hair tonic can reduce hair loss and improve hair quality.
1 citations
,
October 2023 in “WORLD SCIENTIFIC eBooks” Amazigh women in Morocco have lost control over argan oil production, limiting their roles and benefits.
16 citations
,
July 2017 in “Rheumatology and Therapy” Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.
May 2024 in “International Seven Journal of Multidisciplinary” More research is needed to better understand and treat Fibrosing Frontal Alopecia.
January 2024 in “The Egyptian Journal of Hospital Medicine” Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.
January 2025 in “Journal of Crohn s and Colitis” Tofacitinib is effective and safe for elderly patients with ulcerative colitis.
August 2023 in “Journal of Investigative Dermatology” Dutasteride may help treat frontal fibrosing alopecia.
1 citations
,
February 2023 in “Journal of Cosmetic Dermatology” 1 citations
,
July 2021 in “Dermatologic Therapy” 1 citations
,
November 2019 in “Dermatologic Therapy” December 2025 in “Lasers in Surgery and Medicine” February 2025 in “International Journal of Dermatology” February 2025 in “Australasian Journal of Dermatology” October 2022 in “Journal of Cosmetic Dermatology” May 2021 in “FEBS open bio” January 2021 in “Dermatologic Therapy” November 2020 in “Dermatologic Therapy” August 2020 in “International Journal of Dermatology” May 2020 in “Dermatologic Therapy” March 2020 in “Dermatologic Therapy” February 2020 in “Stem Cells Translational Medicine” January 2020 in “Dermatologic Therapy”
October 2018 in “Journal of the European Academy of Dermatology and Venereology” January 2018 in “International Journal of Dermatology”
2 citations
,
September 2021 in “Curēus” Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.
October 2021 in “International Journal of Cosmetic Science” September 2025 in “International Journal of Dermatology” November 2023 in “Veterinary Dermatology”
April 2019 in “Actas Dermo-Sifiliográficas” The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.